Nasogastric Tube Market Size, Share, Growth, and Industry Analysis, By Type (Levin tube, Sengstaken-Blakemore tube, Others), By Application (Children Use, Adult Use), Regional Insights and Forecast to 2035

Nasogastric Tube Market Overview

The global Nasogastric Tube Market size estimated at USD 317.6 million in 2026 and is projected to reach USD 441.38 million by 2035, growing at a CAGR of 3.72% from 2026 to 2035.

The global Nasogastric Tube Market is centered on singleuse medical devices used for gastric decompression, enteral feeding, medication delivery, lavage, aspiration, and selected emergency procedures. In 2026, Levin tubes are estimated to represent 50.1% of the nasogastric tubes market by product type, reflecting their established use across hospitals and emergency departments. North America is estimated to account for 39.3% of global market activity in 2026, making it the leading regional market. Nasogastric tubes are manufactured in multiple French sizes, with products commonly offered at 8F, 10F, 12F, 14F, 16F, and 18F. PVC, polyurethane, silicone, radiopaque markings, antireflux filters, and specialized connectors are important product characteristics.

The United States represents the largest national market within North America, supported by approximately 6,100 hospitals and extensive intensivecare, emergencycare, neonatal, and longtermcare infrastructure. Nasogastric tube products are used for shortterm nutritional support, gastric decompression, medication administration, and aspiration management. Cardinal Health maintains multiple gastrointestinal tube products, including 8F nasogastric and nasoenteral devices, while BD offers nasogastric products in several French sizes and lengths, including 10F, 14F, 16F, and 18F configurations. In 2023, a Cardinal Health Argyle Levintype stomach tube was listed for commercial distribution with a package quantity of 50 units.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Approximately 73.8% of the patientgroup market is represented by adults when the reported 26.2% pediatric share is applied to the two broad patient categories, supporting strong demand for adult nasogastric feeding, decompression, medication delivery, and emergency gastrointestinal management.

• Major Market Restraint: Approximately 100% of nasogastric tube placement procedures require appropriate clinical verification because incorrect placement can create serious complications; placementrelated safety requirements therefore remain a major restraint affecting training, workflow, monitoring, and hospital procurement decisions.

• Emerging Trends: Approximately 50.1% of the product market is attributed to Levin tubes, while 35.2% is associated with enteral feeding applications, demonstrating continued demand for versatile tubes alongside increasing interest in flexible materials, improved connectors, antireflux systems, and placementverification technologies.

• Regional Leadership: North America holds approximately 39.3% of the global nasogastric tubes market in 2026, while AsiaPacific represents approximately 27.2%, confirming North American leadership and AsiaPacific's substantial position in global consumption, supported by healthcare infrastructure and expanding clinical utilization.

• Competitive Landscape: The market includes approximately 9 major companies specified in this report, with established manufacturers competing through product breadth, Frenchsize availability, connector design, material selection, hospital distribution, and regulatory compliance rather than through a single dominant product configuration.

• Market Segmentation: Levin tubes account for approximately 50.1% of product demand, while pediatric users represent approximately 26.2% of the patient market, demonstrating the importance of established tube designs and agespecific products within global nasogastric tube market segmentation.

• Recent Development: Approximately 2 specialized Tumguide Fiber specifications, 0.5 mm and 0.75 mm, were introduced in November 2024 for pediatric nasogastric tubetip visualization, demonstrating increasing attention to placement verification and agespecific nasogastric tube safety technologies.

Nasogastric Tube Market Latest Trends

The Nasogastric Tube Market is increasingly focused on patient safety, tube flexibility, placement accuracy, and connector compatibility. In 2026, Levin tubes hold an estimated 50.1% share, confirming that established singlelumen designs remain commercially important even as manufacturers introduce more advanced products. PVC remains widely used because of its manufacturing practicality, while polyurethane and silicone are increasingly considered where softness, flexibility, and patient comfort are priorities. BD offers products with radiopaque stripes, PreVent antireflux filters, and Lopez Valve connectors, demonstrating the market's movement toward integrated functionality rather than basic tubing alone.

Placement verification is another major trend. In September 2023, Otsuka Pharmaceutical Factory announced Tumguide LED Light Source and Tumguide Fiber for visual checking of nasogastric tubetip position. In November 2024, the company introduced 0.5 mm and 0.75 mm Tumguide Fiber specifications for pediatric treatment. Artificial intelligence is also entering the placementverification workflow, with a 2024 clinical design study involving 15 healthcare stakeholders examining AIassisted identification of nasogastric tube position on radiographic images. These developments indicate that future Nasogastric Tube Market demand will increasingly involve safety accessories and verification technologies alongside the tube itself.

Nasogastric Tube Market Dynamics

The Nasogastric Tube Market is shaped by clinical demand, hospital procurement, emergencycare requirements, nutritional support, gastrointestinal procedures, regulatory requirements, and product safety. The market is particularly sensitive to changes in hospital admissions, intensivecare utilization, neonatal care, dysphagia management, stroke rehabilitation, gastrointestinal disease treatment, and postoperative care. Products are generally disposable or intended for shortterm use, making recurring hospital consumption an important demand factor. Product differentiation increasingly depends on tube material, lumen structure, radiopaque markers, connectors, antireflux systems, placement aids, and patientspecific sizing. BD, Cardinal Health, Andersen Products, Rontis, Bicakcilar, and other manufacturers compete across these attributes.

DRIVER

Rising demand for enteral nutrition and gastric decompression.

The primary driver of the Nasogastric Tube Market is the continuing requirement for shortterm enteral nutrition and gastric decompression in hospitals. Enteral feeding represented 35.2% of the broader nasogastric tubes market application mix in 2026, demonstrating the importance of nutritional support as a major use case. Nasogastric tubes are also used for medication delivery, lavage, aspiration, and decompression, creating multiple demand pathways within a single medicaldevice category.Demand is reinforced by neurological disorders, swallowing impairment, critical illness, postoperative gastrointestinal dysfunction, and emergency conditions. Adult users represent approximately 73.8% of the twocategory patient mix when compared with the reported 26.2% pediatric share. Hospitals therefore remain the principal procurement environment because patients requiring nasogastric access frequently need professional placement, monitoring, and feeding management. 

RESTRAINT

Placementrelated safety risks and clinical verification requirements.

Nasogastric tube placement is technically straightforward but clinically sensitive because incorrect positioning can result in serious patient harm. The requirement for appropriate confirmation increases clinical workload and can influence procurement toward products offering radiopaque markings, weighted tips, placement aids, or other safety features. A 2024 study on AIassisted tubeplacement qualification highlighted the complexity of integrating automated placement verification into actual clinical workflows and involved 15 healthcare stakeholders.Product performance issues can also affect hospital confidence. A 2024 FDArecorded Cardinal Health incident involved an 8F weighted/stylet nasogastric tube in which the weighted tip and tubing became disconnected. Another 2024 report involved leakage at the connection of a Cardinal Health nasogastric feed tube with an ENFit connector.

OPPORTUNITY

Development of safer, softer, and placementassisted nasogastric tubes.

The strongest opportunity in the Nasogastric Tube Market lies in products that reduce placement difficulty while improving patient comfort and clinical visibility. North America accounted for approximately 39.3% of the global nasogastric tubes market in 2026, giving manufacturers a strong commercial base for advanced products. At the same time, AsiaPacific represented approximately 27.2%, creating a substantial opportunity for scalable products that combine safety, affordability, and broad size availability.Pediatric products represent another important opportunity because pediatric patients require smaller tube dimensions and more specialized handling. The pediatric segment represented approximately 26.2% of the patientgroup market in 2026. Otsuka's introduction of 0.5 mm and 0.75 mm opticalfiber specifications for pediatric use in 2024 illustrates how product development is becoming more agespecific.

CHALLENGE

Balancing clinical safety, product cost, and manufacturing complexity.

Manufacturers face the challenge of producing tubes that are flexible enough for patient comfort while maintaining sufficient structural integrity during insertion and use. Adding radiopaque stripes, antireflux filters, specialized valves, weighted tips, or opticalfiber compatibility can increase component complexity. BD's current product portfolio demonstrates the number of configurations required by hospitals, including 10F, 14F, 16F, and 18F tubes as well as multiple lengths and connector arrangements.Another challenge is maintaining reliable supply across multiple French sizes and clinical applications while meeting medicaldevice regulatory requirements. Hospitals can require standardized connectors, secure packaging, consistent dimensions, and documented performance. The emergence of ENFitcompatible products also requires manufacturers to maintain connector compatibility across feeding systems.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

Segmentation Analysis

The Nasogastric Tube Market is segmented by type and application, with Levin tube, SengstakenBlakemore tube, and other specialized designs representing the principal product categories specified for this market. Levin tubes are the largest segment, holding an estimated 50.1% share in 2026 in the broader current market classification. Application segmentation divides demand into children use and adult use, with pediatric patients accounting for approximately 26.2%, leaving adult use as the dominant category at approximately 73.8% when the two categories are treated as mutually exclusive. Hospitals, intensivecare units, emergency departments, neonatal units, and specialized clinics remain important consumption points.

By Type

Levin Tube

Levin tubes represent the largest product category in the current Nasogastric Tube Market, with an estimated 50.1% share in 2026. The design is generally associated with a single lumen and side openings that support gastric aspiration, decompression, feeding, and medication administration. Its established clinical familiarity gives it an advantage in hospitals where standardized procedures and routine purchasing are important. BD currently offers Levin tubes in configurations such as 10F and 12F with 48inch lengths, demonstrating the continued commercial relevance of the traditional design. The availability of radiopaque materials and transparent tubing also supports visualization during clinical use.The Levin tube segment benefits from broad application across adult and pediatric care, although specific sizing must be matched to the patient. 

SengstakenBlakemore Tube

SengstakenBlakemore tubes occupy a specialized position in the Nasogastric Tube Market because they are primarily associated with emergency management of severe upper gastrointestinal bleeding, particularly esophageal variceal bleeding. A current market assessment places this segment at approximately 14.3% in a specialized global market calculation, highlighting its meaningful but narrower role compared with generalpurpose Levin tubes. The design uses balloonbased tamponade principles and therefore requires trained clinical personnel, careful monitoring, and emergencycare infrastructure.The segment is supported by demand from hospitals with gastroenterology, hepatology, intensivecare, and emergency departments. Its use is less routine than general enteral feeding tubes, but clinical urgency makes reliable availability important. 

By Application

Children Use

Children use represents approximately 26.2% of the broader nasogastric tubes patientgroup market in 2026. Pediatric nasogastric tube demand is influenced by neonatal feeding difficulties, prematurity, swallowing disorders, congenital conditions, postoperative care, and temporary nutritional support. Pediatric products require careful attention to tube diameter, flexibility, length, securement, and placement verification because anatomical dimensions differ substantially from adults. The development of 0.5 mm and 0.75 mm Tumguide Fiber specifications in 2024 specifically for pediatric treatment demonstrates the increasing emphasis on pediatric placement safety.Pediatric hospitals and neonatal intensivecare units are major demand centers. Manufacturers can differentiate through smallbore tubes, softer materials, radiopaque markers, weighted tips, and placementverification technologies.

Adult Use

Adult use represents approximately 73.8% of the twocategory application structure when the reported 26.2% pediatric share is deducted from 100%. Adult demand is driven by criticalcare nutrition, postoperative decompression, strokerelated dysphagia, gastrointestinal disorders, medication delivery, aspiration management, and emergency procedures. Hospitals and intensivecare units represent the principal institutional users because adult patients requiring nasogastric access often require continuous monitoring and multidisciplinary nutritional management.The adult segment also supports a wider range of tube sizes and clinical functions. BD offers adult nasogastric sump tubes in 14F, 16F, and 18F sizes and 48inch lengths, alongside a 10F configuration with a 36inch length. 

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Nasogastric Tube Market Regional Outlook

The regional Nasogastric Tube Market is led by North America, which accounted for approximately 39.3% of the global market in 2026. AsiaPacific followed with approximately 27.2%, reflecting expanding healthcare capacity and increasing clinical demand. Europe remains a mature market supported by established hospital systems, while Middle East & Africa presents opportunities linked to healthcare infrastructure expansion. Historical market assessments also recorded strong European consumption, with Europe representing 25.55% of global consumption in 2015, while China represented 25.11% during the same historical period.

North America

North America held approximately 39.3% of the global nasogastric tubes market in 2026, establishing the region as the leading geographic market. The United States represents the principal country because of its large hospital network, advanced intensivecare capacity, established medicaldevice distribution, and high adoption of standardized clinical protocols. Canada contributes additional demand through public hospitals and specialized healthcare facilities. Manufacturers benefit from established procurement systems and the presence of major medicaldevice companies with extensive distribution capabilities.Product availability is a major competitive advantage in North America. BD provides multiple nasogastric configurations, including 10F, 14F, 16F, and 18F products, while Cardinal Health maintains 8F nasogastric and nasoenteral products. This broad size availability supports clinical requirements across adults, children, intensivecare patients, and emergency departments. 

Europe

Europe remains a mature Nasogastric Tube Market supported by established hospital systems, extensive public healthcare infrastructure, and high utilization of enteral nutrition in acute and chronic care. Historical data placed European nasogastric tube consumption at 25.55% of global consumption in 2015, demonstrating the region's longstanding importance. Germany, the United Kingdom, France, Italy, and Spain represent important national markets because of their developed hospital networks and established clinical standards.European demand is influenced by aging populations, stroke management, oncology care, neurological disorders, postoperative nutrition, and intensivecare services. Nasogastric tubes are frequently used when oral feeding is temporarily unsafe or insufficient. European procurement also emphasizes device safety, documentation, material quality, and regulatory compliance. 

AsiaPacific

AsiaPacific accounted for approximately 27.2% of the global nasogastric tubes market in 2026, making it the secondlargest regional market. The region includes major healthcare markets such as China, Japan, India, South Korea, and Australia, with demand supported by large patient populations, expanding hospital infrastructure, and increasing access to specialized medical care. Historical market data also identified China as a major consumer, with 25.11% of global consumption reported in 2015.China is important both as a consumption market and manufacturing center. Guangdong Baihe Medical Technology is among the manufacturers active in nasogastric tube products, while Japanese companies are developing placementsupport technologies. In September 2023, Otsuka Pharmaceutical Factory announced Tumguide LED Light Source and Tumguide Fiber, and in November 2024 it expanded Tumguide Fiber specifications to 0.5 mm and 0.75 mm for pediatric treatment.

Middle East & Africa

The Middle East & Africa Nasogastric Tube Market is smaller than North America, Europe, and AsiaPacific but presents opportunities through hospital modernization, emergencycare expansion, and increasing access to specialized nutrition services. Demand is concentrated in major healthcare centers in countries such as Saudi Arabia, the United Arab Emirates, South Africa, and other markets with expanding tertiarycare infrastructure. Hospitals remain the principal users because nasogastric tubes are frequently required in intensive care, emergency medicine, surgery, and gastrointestinal management.The region's market opportunity is strongly influenced by procurement economics and product availability. Hospitals require reliable disposable devices across common French sizes, with products that support feeding, aspiration, and decompression. Manufacturers that can provide standardized packaging, consistent quality, and efficient distributor support can improve penetration.

List of Top Nasogastric Tube Market Companies

• Guangdong Baihe Medical Technology
• Andersen Products
• Q Holding Company
• GBUK Group Ltd.
• Rontis
• Bicakcilar
• Pacific Hospital Supply

List of Top tow Companies Market Share

• BD: BD is one of the leading global nasogastric tube suppliers, supported by a broad portfolio covering multiple French sizes, radiopaque tubing, antireflux filtration, and securement systems. A precise standalone global percentage share for BD is not publicly disclosed in the available market data; however, the company is consistently identified among the leading manufacturers.

• Cardinal Health: Cardinal Health is another leading supplier with Salem, Argyle, nasogastric, and nasoenteral products. Its publicly listed portfolio includes 8F ENFitcompatible devices and Levintype stomach tubes. A precise standalone global percentage share is not publicly disclosed, so assigning an unsupported numerical percentage would not represent verified market data.

Investment Analysis and Opportunities

Investment opportunities in the Nasogastric Tube Market are concentrated in product safety, manufacturing efficiency, pediatric solutions, advanced materials, connector compatibility, and placement verification. North America represents the largest regional opportunity with approximately 39.3% of the global market in 2026, while AsiaPacific represents approximately 27.2%. Investors targeting these regions can prioritize manufacturing capacity, local distribution, and product registration.A major investment area is advanced placement technology. Otsuka Pharmaceutical Factory introduced Tumguide components in 2023 and expanded pediatric opticalfiber specifications in 2024, demonstrating commercial interest in visual tubeposition verification.

AIassisted radiographic verification is another emerging area, with a 2024 study involving 15 healthcare stakeholders examining clinical workflow requirements. Investments in these technologies can create differentiated product ecosystems rather than relying exclusively on conventional tubing.Manufacturing investments can also target smallbore pediatric tubes, soft polyurethane products, radiopaque PVC tubes, ENFitcompatible connectors, antireflux filters, and weightedtip systems. The 50.1% share associated with Levin tubes confirms the continuing importance of established products, while the 26.2% pediatric share demonstrates a significant opportunity for specialized agespecific designs.

New Product Development

New product development in the Nasogastric Tube Market is increasingly focused on reducing placement errors, improving patient comfort, increasing connector reliability, and supporting specialized clinical applications. Current BD products demonstrate this approach through radiopaque stripes, PreVent antireflux filters, Lopez Valve connectors, and multiple tube sizes. Available configurations include 10F, 14F, 16F, and 18F products, showing the importance of clinical customization.Placementsupport technology represents one of the most important innovation areas. In October 2023, Otsuka Pharmaceutical Factory launched Tumguide LED Light Source and Tumguide Fiber, allowing visual assessment of nasogastric tubetip position through an opticalfiber approach.

In November 2024, the company added 0.5 mm and 0.75 mm fiber specifications intended for pediatric treatment. These developments show how nasogastric tube innovation is extending beyond the tube itself toward verification systems.Digital technology is also influencing product development. A 2024 research initiative studied AIassisted identification of nasogastric tube placement using radiographic images and involved 15 clinical stakeholders. The development direction indicates potential integration between medical imaging, automated positioning assessment, clinical decision support, and tubeplacement workflows. Manufacturers that combine physical tube improvements with digital verification may gain differentiation in a market increasingly focused on patient safety.

Five Recent Developments (20232025)

• October 2023 — Otsuka Pharmaceutical Factory: Otsuka Pharmaceutical Factory launched Tumguide LED Light Source and Tumguide Fiber as components of a system designed to visually check nasogastric tubetip position. The launch represented a shift toward direct placement verification and used opticalfiber technology to provide visual information during insertion. The products were scheduled for launch on October 17, 2023.
• November 2023 — Cardinal Health: Cardinal Health added an Argyle Stomach Tube Levin Type to commercial distribution, with a device record published in November 2023. The listed product was a singleuse Class II device with a package quantity of 50 units, demonstrating continued investment in established Levintype gastrointestinal tube products.
• May 2024 — AI Placement Verification Research: A 2024 clinical research project investigated AIassisted qualification of nasogastric tube positioning using radiographic images. The research involved 15 healthcare stakeholders and examined workflow integration, clinical usefulness, data limitations, and safety considerations. The work demonstrates growing technology development around automated nasogastric tube placement verification.
• November 2024 — Otsuka Pharmaceutical Factory: Otsuka Pharmaceutical Factory introduced additional Tumguide Fiber specifications with outer diameters of 0.5 mm and 0.75 mm for pediatric treatment. The fibers were designed to work with the Tumguide LED Light Source and support visual checking of nasogastric tubetip position in pediatric patients.
• 2025 — Bard/BD Product Activity: Bardbranded nasogastric sump tube products continued to appear in U.S. medicaldevice surveillance records during 2025, including Bard Nasogastric Sump Tube with PreVent products. The continued commercial presence of these products demonstrates ongoing demand for established antireflux and gastricdecompression configurations in the U.S. clinical market.

Report Coverage of Nasogastric Tube Market

The Nasogastric Tube Market report covers product type, application, regional performance, competitive positioning, product development, investment opportunities, market dynamics, and manufacturer strategies. The principal type categories analyzed are Levin tube, SengstakenBlakemore tube, and Others, while the application structure includes Children Use and Adult Use. The report evaluates market performance across North America, Europe, AsiaPacific, and Middle East & Africa.The report emphasizes measurable market indicators such as the 50.1% share attributed to Levin tubes, the 26.2% pediatric patient share, the 73.8% implied adult share within the twocategory application structure, the 39.3% North American regional share, and the 27.2% AsiaPacific regional share reported for 2026.

Competitive coverage includes 9 specified manufacturers: BD, Cardinal Health, Guangdong Baihe Medical Technology, Andersen Products, Q Holding Company, GBUK Group Ltd., Rontis, Bicakcilar, and Pacific Hospital Supply. Product analysis considers French sizes, materials, radiopaque markings, connectors, antireflux systems, and placementsupport features. BD's portfolio includes 10F, 14F, 16F, and 18F configurations, while Cardinal Health maintains 8F nasogastric and nasoenteral products, illustrating the breadth of available configurations.The report also covers innovation activity between 2023 and 2025, including Otsuka Pharmaceutical Factory's 2023 Tumguide launch, its 2024 pediatric fiber expansion, Cardinal Health's 2023 Levintype product listing, AIassisted placementverification research involving 15 stakeholders, and continued Bard nasogastric sump tube activity during 2025.

Nasogastric Tube Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 317.6 Million in 2026
Market Size Value By	USD 441.38 Million by 2035
Growth Rate	CAGR of 3.72% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Levin tube Sengstaken-Blakemore tube Others By Application : Children Use Adult Use
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample